about us

Reveal Biosciences is creating a new generation of data powered pathology to enhance research and improve global healthcare. 

our story

Cancer has impacted the lives of many of our friends and family.  Reveal was founded in 2012 by Claire Weston and Casey Laris with a vision towards pathology driven by data.  Our team is creating artificial intelligence technologies for whole slide pathology images that increase accuracy, reproducibility and scale.  If the technology we’re building today had been available 15 years ago, a cancer misdiagnosis in Casey’s own family would likely have been caught.  We see that by taking a quantitative approach, the data generated by our tools  benefits preclinical research, clinical trials, and ultimately patients.

the leadership team

Claire Weston, PhD

Casey Laris

Ami Lau
Director of Operations

Ivana Mikic, PhD
Director of AI

Erika Hong

Histology Group Leader

scientific advisory board

Cory Roberts
CEO, ProPath

Christine Valladolid
Executive Director, Kaiser

Our Partners

We are proud to partner with the following organizations

News & Articles

Latest research, in the news, or at events.

Contact Us

Reach out to our friendly team

Learn how data powered pathology can enhance your research, clinical trial, or pathology workflow.

Claire Weston

Founder & CEO

Dr. Claire Weston is an accomplished and dedicated
scientific leader with a track record of success in cancer research. She was awarded a Ph.D. in Cell Biology from Cambridge University in the U.K. and has led teams and projects focused on cancer
biomarkers in both large pharma and start-up
environments. Claire founded Reveal Biosciences in 2012 and the company has since demonstrated strong year-on-year growth. She has authored numerous peer-reviewed publications in leading journals including Science, and is a respected
member of multiple professional organizations
including the Digital Pathology Association.

Casey Laris

Co-Founder & CTO

Casey Laris, CTO, leads the machine learning development of AI-based diagnostics at Reveal. He is a world leader in high-throughput biological computer vision and has been at the forefront of analyzing big data sets from automated microscopy in pathology. Casey developed patented high-throughput microscopy technology at UCSD and productized it in a venture-backed start-up that was later acquired by Beckman-Coulter. There he was Global Product Manager for high content microscopy, reagents and software, leading both the world-wide roll-out and follow-on clinical-ready instrumentation development. Casey helped further develop these computer vision tools at Sanford Burnham Prebys Medical Discovery Institute with commercialization by Biovia. Casey lead the applications and engineering team at Vala Sciences to create several novel automated high throughput microscope-based systems.  Casey holds a BS from UC San Diego.

Ami Lau

Director of Operations

Ami Lau is a senior member of the Reveal team and leads Operations and Human Resources. Ami is responsible for client satisfaction, efficient operations and maintaining a collaborative and innovative company culture. With 15 years of previous Human Resources Management experience at National Instruments and other large companies, Ami is focused on scalability as Reveal continues to grow.  Ami holds a Master’s degree in Management from the College of Notre Dame and a Bachelor’s degree in Industrial Psychology from the University of Maryland.

Ivana Mikic

Director of AI

Dr. Mikic leads the Image Analysis and AI teams at Reveal. She is a computer vision and machine learning expert with extensive experience in software design. Her career has been focused on biological and medical image analysis and she is passionate about contributing to new biological and medical insights and advances that latest technologies make possible. She was awarded her PhD in Electrical and Computer Engineering from the University of California, San Diego and her MS in Biomedical Engineering from Ohio State University. Dr. Mikic was a Ramon y Cajal professor at Universidad Autónoma de Madrid. She co-founded Image Informatics, where she led the development of computer vision tools that were acquired by Biovia in 2016.

Cory Roberts

CEO, ProPath

Cory is the President and CEO of ProPath, one of the largest physician-owned pathology companies in the US. ProPath comprises nearly 50 physicians and over 400 employees serving patients in 45 states plus several foreign countries. ProPath has a nationwide sales force and medically directs 25 hospitals. Cory is also an advisor to Glenview Capital Management (London & New York), and serves on the Graduate Medical Education Committee for the College of American Pathologists. He has published numerous peer-reviewed papers, book chapters, and has testified before Congress regarding the laboratory workflow shortage.

Christine Valladolid

Executive Direction, Kaiser Permanente

Christine is the Executive Director of Enterprise Leadership and Organizational Effectiveness at Kaiser Permanente. She has been with KP for more than a decade and has served in organizational strategy, technology governance, and program management. Before joining KP, she worked in technology consulting at Capgemini. She holds a doctorate in Organizational Leadership from Pepperdine University, an M.B.A. from Vanderbilt University and a B.A. from Penn State. She is an adjunct professor at the University of Redlands and teaches courses in the university’s Healthcare Administration and Project Management programs.

Pathology Revealed

Sign up to receive updates on the latest AI-powered pathology breakthroughs, access digital pathology resources, and more.